ESMO ESMO Data Sharpens View of How Grail, Exact Sciences Multi-Cancer Early Detection Tests Perform Premium Grail released updated data on Galleri from the PATHFINDER study, while Exact reported retrospective analysis on the performance of its test. Repeat Biomarker Testing Informs Next Steps for Treatment-Resistant EGFR-Mutant NSCLC Patients Premium Studies at ESMO showed the importance of repeat biomarker testing to guide treatment after resistance to AstraZeneca's Tagrisso, but tissue-based testing remains a hindrance. ESMO Releases Guidelines for Liquid Biopsy Testing in Cancer Patients While the society endorsed widely used ctDNA genotyping to guide therapy in advanced cases, it rated most other emerging applications as unproven. ESMO Oncologists Debate Optimal Timing for Broad NGS, Align on Key Barriers to Precision Oncology Premium Oncologists argued for and against comprehensive NGS at the point of diagnosis but agreed on the need to address quality and cost barriers first. Agendia Adds to Data Supporting Breast Cancer Assay in Guiding Long-Term Endocrine Therapy Use Premium Recently presented data confirm prior findings that Agendia's MammaPrint may help doctors decide whether to limit tamoxifen treatment in certain patients. Sep 24, 2020 Spain's Universal Diagnostics Bets on Cell-Free DNA Methylation for Early-Stage Cancer Detection Premium Sep 23, 2020 Multi-Biomarker Strategies Show Promise in Improving Immunotherapy Response Prediction Premium Sep 22, 2020 Metastatic Cancer Treatment Markers Identified in Clinical WGS Study Sep 20, 2020 HPV, p16 May Offer Different Prognostic Clues in Oropharyngeal Cancer, ESMO Data Reveals Premium Aug 25, 2020 ESMO Recommendations Outline Use of Next-Gen Sequencing in Metastatic Cancer Patients Sep 30, 2019 Netherlands Drug Repurposing, Tumor Profiling Trial Results Reported at ESMO Sep 30, 2019 TAILORx High-Risk Group Analysis Adds to Oncotype DX Chemo-Prediction Data Sep 30, 2019 Carcinoma of Unknown Primary Investigators Pursue Molecular Targets to Tailor Treatments Premium Sep 29, 2019 Researchers Identify Possible Methylation Signature for Brain Metastases of Lung Cancer Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.